ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COG Cambridge Cognition Holdings Plc

54.50
-0.50 (-0.91%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cambridge Cognition Holdings Plc LSE:COG London Ordinary Share GB00B8DV9647 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.91% 54.50 54.00 55.00 54.50 54.50 54.50 20,004 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 12.61M -409k -0.0117 -46.58 18.99M

Cambridge Cognition Holdings PLC Appointment of Non-Executive Director (9043D)

01/07/2019 7:00am

UK Regulatory


Cambridge Cognition (LSE:COG)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Cambridge Cognition Charts.

TIDMCOG

RNS Number : 9043D

Cambridge Cognition Holdings PLC

01 July 2019

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Appointment of Non-Executive Director

The neuroscience technology company, Cambridge Cognition Holdings plc (AIM: COG), which develops and markets neuroscience technologies to assess brain health, is pleased to announce the appointment of Debra Leeves as a Non-Executive Director with immediate effect.

Debra is currently CEO of Vertual, the leading provider of virtual and augmented reality training simulation systems in radiotherapy. She has over 25 years of experience in the medical technology and biotechnology industries, and has previously been COO of Beckley Canopy Therapeutics, CEO of Physeon and also held senior roles with companies such as Rex Bionics, Avita Medical, Merck, GlaxoSmithKline, GE Healthcare and Pfizer.

Matthew Stork, CEO of Cambridge Cognition said:

"We are delighted that Debra has joined the Board. Debra brings with her an immense amount of knowledge and expertise in successful global medical technology businesses and clinical trial management within major pharmaceutical companies. Her experience will be invaluable as we continue the growth of Cambridge Cognition."

The following information regarding Debra Marie Leeves (aged 57) is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 
 Current Directorships    Directorships held in past 5 years 
 Vertual Limited          Physeon GmbH 
  Oxford Box Ltd 
  DML Solutions Limited 
 

As at the date of this announcement, Mrs Leeves is not beneficially interested in any Ordinary Shares in the Company.

There are no other matters which are required to be announced under Schedule 2(g) of the AIM Rules for Companies.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Enquiries

 
 Cambridge Cognition Holdings PLC 
  Matthew Stork, Chief Executive Officer      Tel: 01223 810 700 
  Nick Walters, Chief Financial Officer       press@camcog.com 
 finnCap Ltd (NOMAD and Joint Broker)       Tel: 020 7220 0500 
  Geoff Nash / Simon Hicks                   (Corporate Finance) 
  Alice Lane / Manasa Patil                  (ECM) 
 Dowgate Capital Limited (Joint Broker)     Tel: 020 3903 7715 
  David Poutney / James Serjeant 
 IFC Advisory Ltd (Financial PR and IR)     Tel: 020 3934 6630 
  Tim Metcalfe / Miles Nolan / Zach Cohen 
 

About Cambridge Cognition

Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.

For further information visit www.cambridgecognition.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCBUGDLCDDBGCI

(END) Dow Jones Newswires

July 01, 2019 02:00 ET (06:00 GMT)

1 Year Cambridge Cognition Chart

1 Year Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

Your Recent History

Delayed Upgrade Clock